1. Home
  2. BYFC vs STXS Comparison

BYFC vs STXS Comparison

Compare BYFC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

N/A

Current Price

$11.66

Market Cap

104.4M

Sector

Finance

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.19

Market Cap

86.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BYFC
STXS
Founded
1946
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.4M
86.4M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
BYFC
STXS
Price
$11.66
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $3.00
AVG Volume (30 Days)
2.1K
★ 723.1K
Earning Date
07-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 16.67
EPS
★ 0.07
N/A
Revenue
$184,000.00
★ $29,346,617.00
Revenue This Year
N/A
$6.04
Revenue Next Year
N/A
$33.01
P/E Ratio
$165.71
★ N/A
Revenue Growth
★ 18.71
N/A
52 Week Low
$5.51
$0.80
52 Week High
$12.35
$2.89

Technical Indicators

Market Signals
Indicator
BYFC
STXS
Relative Strength Index (RSI) 63.80 61.26
Support Level $11.76 $0.95
Resistance Level $12.27 $1.97
Average True Range (ATR) 0.14 0.09
MACD 0.06 0.03
Stochastic Oscillator 100.00 97.47

Price Performance

Historical Comparison
BYFC
STXS

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank offers a variety of commercial real estate loan products, services, and depository accounts that support investments in affordable housing, small businesses, and nonprofit community facilities located within low-to-moderate income neighborhoods.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: